Detalhe da pesquisa
1.
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Nature
; 566(7745): E11-E12, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755741
2.
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Nature
; 554(7691): 189-194, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420467
3.
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 159(1): 150-156, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723675
4.
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).
Sci Signal
; 11(551)2018 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301790